BioNTech, known for its COVID-19 vaccine, is transitioning toward cancer therapy development. Fourth-quarter 2024 earnings fell to €1.08 per share but surpassed market expectations despite declining revenue. Annual results show…
A critical decision is pending regarding healthcare providers for 8,000 Spanish officials abroad. Only Nueva Mutua Sanitaria remains in the bidding, pending a thorough review by Muface. The evaluation committee…
Argentina's government has officially announced its withdrawal from the WHO, citing sovereignty concerns. This move parallels the U.S. position, reflecting growing distrust of global health institutions. Close ties between Argentine…